Abstract
Translocations involving 11q23 are among the most common genetic abnormalities in hematologic malignancies, occurring in approximately 5–10% of acute lymphoblastic leukemia (ALL) and 5% of acute myeloblastic leukemia (AML). In 11q23 translocations, the mixed lineage leukemia (MLL) gene on chromosome 11, band q23, is usually disrupted. The human homologue of the rat NG2 chondroitin sulfate proteoglycan molecule, as detected by the monoclonal antibody (moab) 7.1, was shown to be expressed on leukemic cells with MLL rearrangements of children with acute leukemia. We further investigated the reactivity of the moab 7.1 on 533 cell samples of adults (n = 215) and children (n = 318) with acute leukemias (271 AML, 217 B-lineage ALL, 37 T-lineage ALL, eight CD7+ CD56+ myeloid/natural killer cell precursor acute leukemias) by flow cytometry. In AML, 38 samples were positive for moab 7.1 (‘20%-cut-off-level’). These moab 7.1-positive AML cases revealed a myelomonocytic-differentiated immunophenotype with coexpression of the NK cell marker CD56 in 33 of 38 cases. Two of eight cell samples of the recently described CD7+ CD56+ myeloid/natural killer cell precursor acute leukemia entity reacted with moab 7.1. In ALL, 35 samples mostly of the pro-B-ALL subtype (33 pro-B-ALL, one common-ALL, one pre-B-ALL) were positive for moab 7.1. 58 (81%) of 72 samples with MLL rearrangements were positive for moab 7.1 including 28/31 with a t(4;11), 16/17 with a t(9;11), 3/5 with a t(11;19), and 2/6 with a del(11)(q23). All moab 7.1-positive ALL (n = 34) and childhood AML (n = 17) cases revealed MLL rearrangements as detected by Southern blot analysis and RT-PCR. However, 11 adults with AML, and one adult with moab 7.1-positive CD7+ CD56+myeloid/natural killer cell precursor acute leukemia were negative for MLL rearrangements as proved by Southern blot analysis. We conclude that moab 7.1 is a sensitive but not entirely specific marker for the identification of 11q23-associated AML and ALL by flow cytometry in children and adults.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Smith FO, Rauch C, Williams DE, March CJ, Arthur D, Hilden J, Lampkin BC, Buckley JD, Buckley CV, Woods WG, Dinndorf PA, Sorensen P, Kersey J, Hammond D, Bernstein ID . The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23 Blood 1996 87: 1123–1133
Behm FG, Smith FO, Raimondi SC, Pui CH, Bernstein ID . Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhoodacute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements Blood 1996 87: 1134–1139
Hilden JM, Smith FO, Frestedt JL, McGlennen R, Howells WB, Sorensen PH, Arthur DC, Woods WG, Buckley J, Bernstein ID, Kersey JH . MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia Blood 1997 89: 3801–3805
Ludwig WD, Ritter J, Knapp W, Gadner H, Thiel E, Riehm H . Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia Leukemia 1989 3: 431–439
Rubnitz JE, Behm FG, Downing JR . 11q23 rearrangements in acute leukemia Leukemia 1996 10: 74–82
Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH . Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age Blood 1996 87: 2870–2877
Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R . Prognostic factors in the acute lymphoid and myeloid leukemias of infants Leukemia 1996 10: 952–956
Secker Walker LM . General Report on the European Union Concerted Action Workshop on 11q23, London, UK, May 1997 Leukemia 1998 12: 776–778
Dördelmann M, Reiter A, Borkhardt A, Ludwig WD, Götz N, Viehmann S, Gadner H, Riehm H, Schrappe M . Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia Blood 1999 94: 1209–1217
Look AT . Oncogenic transcription factors in the human acute leukemias Science 1997 278: 1059–1064
Margolis RU, Margolis RK . Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding Cell Tissue Res 1997 290: 343–348
Levine JM, Nishiyama A . The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells Perspect Dev Neurobiol 1996 3: 245–259
Nishiyama A, Dahlin KJ, Stallcup WB . The expression of NG2 proteoglycan in the developing rat limb Development 1991 111: 933–944
Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S . CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity Blood 1997 90: 2417–2428
Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia 1995 9: 1783–1786
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group Br J Haematol 1976 33: 451–458
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
Ludwig WD, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt Jung H, Teichmann JV, Riehm H . Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis Blood 1988 71: 1518–1528
Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Löffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Volkers B, Aydemir U, Fonatsch C, Gökbuget N, Thiel E, Hoelzer D . Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89 Blood 1998 92: 1898–1909
Béné MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F, Ludwig WD, Matutes E, Orfao A, Sperling C, van't Veer MB . The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL) Blood 1998 92: 596–599
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215
Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J, Nishida K, Harbott J, Lampert F . Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis Leukemia 1995 9: 210–215
Mitelman F . ISCN (1995). Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature Karger:Basel, 1995
Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ . Altered Hox expression and segmental identity in Mll-mutant mice Nature 1995 378: 505–508
Lawrence HJ, Largman C . Homeobox genes in normal hematopoiesis and leukemia Blood 1992 80: 2445–2453
Joh T, Hosokawa Y, Suzuki R, Takahashi T, Seto M . Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dc13 cells Oncogene 1999 18: 1125–1130
Magli MC, Largman C, Lawrence HJ . Effects of HOX homeobox genes in blood cell differentiation J Cell Physiol 1997 173: 168–177
Jones FS, Prediger EA, Bittner DA, De Robertis EM, Edelman GM . Cell adhesion molecules as targets for Hox genes: neural cell adhesion molecule promoter activity is modulated by cotransfection with Hox-2.5 and -2.4 Proc Natl Acad Sci USA 1992 89: 2086–2090
Jones FS, Holst BD, Minowa O, De Robertis EM, Edelman GM . Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3) Proc Natl Acad Sci USA 1993 90: 6557–6561
Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G, Rabbitts TH . An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes Cell 1996 85: 853–861
Mielcarek M, Sperling C, Schrappe M, Meyer U, Riehm H, Ludwig WD . Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome Br J Haematol 1997 96: 301–307
Burg MA, Grako KA, Stallcup WB . Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells J Cell Physiol 1998 177: 299–312
Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD . Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87 Blood 1995 86: 3097–3108
Baer MR, Stewart CC, Lawrence D, Arthur DC, Mrozek K, Strout MP, Davey FR, Schiffer CA, Bloomfield CD . Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry Leukemia 1998 12: 317–325
Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH . Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56) Leukemia 1994 8: 823–826
Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J Jr, Kalwinsky DK, Ayers GD, Behm FG . Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children Blood 1992 80: 3182–3188
Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M . The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth J Cell Biol 1994 125: 669–680
Baer MR, Stewart CC, Lawrence D, Arthur DC, Byrd JC, Davey FR, Schiffer CA, Bloomfield CD . Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22) Blood 1997 90: 1643–1648
Acknowledgements
We would like to thank M Martin, K Liebezeit and K Ganzel for their excellent technical assistance and Dr A Schönberger (Beckman Coulter) for kindly providing the moab 7.1 for our investigations. The cell samples included in this study were sent from various hospitals in Germany participating in the ongoing ALL-BFM (coordinators: M Schrappe and H Riehm, Hannover), GMALL (coordinator: D Hoelzer, Frankfurt), AML-BFM (coordinator: U Creutzig, Hannover) and AML-CG (coordinators: T Büchner, Münster; W Hiddemann, München; B Wörmann, Braunschweig; W Berdel, Münster) trials. We thank the coordinators of the above studies for their continuous support as well as all clinicians providing cell samples for our investigations. This work was supported by grants of the ‘Deutsche José Carreras Leukämie Stiftung’ (JCLS 1998/NAT-3 to CW) and the ‘Deutsche Leukämie-Forschungshilfe’ (DLFH-98.04 to VR).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wuchter, C., Harbott, J., Schoch, C. et al. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1. Leukemia 14, 1232–1238 (2000). https://doi.org/10.1038/sj.leu.2401840
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401840
Keywords
This article is cited by
-
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Leukemia (2019)
-
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
Leukemia (2018)
-
Antithetic roles of proteoglycans in cancer
Cellular and Molecular Life Sciences (2012)
-
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
Leukemia (2011)
-
Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement
Leukemia (2011)